[Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS].
D000596:Amino Acids / Q000097:blood / Q000378:metabolism*; D000818:Animals; D001930:Brain Injuries; D002493:Central Nervous System Diseases / Q000378:metabolism*; D002555:Cerebrospinal Fluid / Q000032:analysis; D003545:Cysteine / Q000378:metabolism; D003553:Cystine / Q000378:metabolism; D003937:Diagnosis, Differential; D005998:Glycine / Q000378:metabolism; D006801:Humans; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000378:metabolism*; D010301:Parkinson Disease, Postencephalitic / Q000134:cerebrospinal fluid; D010640:Phenothiazines / Q000494:pharmacology; D051381:Rats; D012694:Serine / Q000378:metabolism; D013912:Threonine / Q000378:metabolism; D014202:Tremor / Q000209:etiology
D000596:Amino Acids; D010640:Phenothiazines; D013912:Threonine; D012694:Serine; D003553:Cystine; D003545:Cysteine; D005998:Glycine
Uber den Zusammenhang zwischen der Parkinson-Symptomatik und einer Störung des Aminosäurehaushaltes im ZNS.